U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C14H16ClNO
Molecular Weight 249.736
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BEXLOSTERIDE

SMILES

[H][C@@]12CCC3=CC(Cl)=CC=C3[C@@]1([H])CCC(=O)N2C

InChI

InChIKey=WQBIOEFDDDEARX-CHWSQXEVSA-N
InChI=1S/C14H16ClNO/c1-16-13-6-2-9-8-10(15)3-4-11(9)12(13)5-7-14(16)17/h3-4,8,12-13H,2,5-7H2,1H3/t12-,13-/m1/s1

HIDE SMILES / InChI

Molecular Formula C14H16ClNO
Molecular Weight 249.736
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

LY 300502 is now called bexlosteride was developed as an inhibitor of the human-specific type I-selective steroid 5alpha-reductase. This drug was studied for patients with prostate cancer, however, has never been marketed.

Originator

Approval Year

PubMed

Substance Class Chemical
Record UNII
36X732P4P0
Record Status Validated (UNII)
Record Version